Prediction Model Clinical Trials

9 recruitingLast updated: May 13, 2026

There are 9 actively recruiting prediction model clinical trials across 3 countries. Studies span Not Applicable. Top locations include Beijing, Beijing Municipality, China, Beijing, China, Hangzhou, Zhejiang, China. Updated daily from ClinicalTrials.gov.


Prediction Model Trials at a Glance

9 actively recruiting trials for prediction model are listed on ClinicalTrialsFinder across 6 cities in 3 countries. The largest study group is Not Applicable with 2 trials, with the heaviest enrollment activity in Beijing, Beijing, and Hangzhou. Lead sponsors running prediction model studies include Peking University People's Hospital, Ruijin Hospital, and Peking University First Hospital.

Browse prediction model trials by phase

Treatments under study

About Prediction Model Clinical Trials

Looking for clinical trials for Prediction Model? There are currently 5 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Prediction Model trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Prediction Model clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 19 of 9 trials

Recruiting
Not Applicable

Develop and Evaluate An Artificial Intelligence Assisted Prehabilitation Program for Returning to Work and Cost-effectiveness Analysis in Patients With Oral Cancer

PhysiotherapyQuality of LifePrehabilitation+11 more
Taipei Veterans General Hospital, Taiwan650 enrolled5 locationsNCT07562100
Recruiting

Predictive Value of Gastrointestinal Blood Flow for Enteral Nutrition Intolerance in Critically Ill Patients

Critical IllnessEnteral Nutrition FeedingMachine Learning+2 more
Ruijin Hospital500 enrolled1 locationNCT07521111
Recruiting

Elderly Patients Undergoing Surgery During Perioperative Period

ElderlyPostoperative ComplicationsPostoperative Delirium (POD)+2 more
Second Affiliated Hospital of Wenzhou Medical University1,200 enrolled1 locationNCT07314762
Recruiting
Not Applicable

Timely Ordering of Pharmacogenetic Testing

PediatricsMachine LearningPrecision Medicine+1 more
The Hospital for Sick Children275 enrolled1 locationNCT06902688
Recruiting

A Prediction Model in Pregnant Women With Aplastic Anemia

PregnancyAplastic AnemiaPrediction Model
Peking University People's Hospital300 enrolled1 locationNCT07101770
Recruiting

Research on Early Prediction Model of Ischemic Cerebrovascular Disease Based on Artificial Intelligence Technology.

Artificial IntelligenceIschemic Cerebrovascular DiseasePrediction Model
Shanghai Jiao Tong University School of Medicine244,296 enrolled1 locationNCT06978348
Recruiting

Dynamic Prediction Model for Patients with Unresectable Biliary Malignancies Receiving Systemic Chemotherapy Combined with Immunotherapy: a Multicenter, Observational Study

ImmunotherapyUnresectable Biliary Tract CancerDynamic Prediction Model
Zhongda Hospital332 enrolled2 locationsNCT06849193
Recruiting

Development and Validation of a Real-time Prediction Model for Acute Kidney Injury in Hospitalized Patients

Prediction Model
Peking University First Hospital161,876 enrolled1 locationNCT06597838
Recruiting

Early Identification of Malignant Brain Edema in laRge Artery oCclusive Stroke After Endovascular Therapy (EMBRACE Study)

Ischemic StrokeEndovascular TherapyBrain Edema+1 more
Zhejiang Provincial People's Hospital1,950 enrolled1 locationNCT06451887